Colby Erickson

Papers

Total Citations

H-Index

About

Colby Erickson is a clinical researcher whose work sits at the intersection of orthopedic surgery and personalized medicine. His primary research focus is on improving postoperative outcomes in total knee arthroplasty (TKA), with a particular emphasis on pain management and the emerging role of pharmacogenomics. In his landmark 2023 randomized trial, "Does Preoperative Pharmacogenomic Testing of Patients Undergoing TKA Improve Postoperative Pain?", Erickson directly tackled the challenge of interindividual variability in analgesic response. This study, which has already garnered 7 citations, was one of the first to rigorously test whether a simple, affordable genetic test could predict how patients metabolize pain medications, thereby allowing surgeons to tailor prescriptions before surgery. By demonstrating the potential for pharmacogenomic testing to reduce adverse drug events and improve pain control, Erickson has opened a new frontier in perioperative care. His work is particularly notable for bridging the gap between genomic science and routine clinical practice, offering a tangible path toward more effective, safer, and personalized orthopedic recovery.